Exclusive: Bloomberg takes you inside AstraZeneca, revealing a culture where mediocrity isn’t tolerated — and where CEO Pascal Soriot maintains pervasive oversight. And we ask the question: Is Astra ready for a future without Soriot? Gift link: www.bloomberg.com/news/feature...

For decades, prostate cancer care has forced men into a cruel choice: 🪓 Remove the whole prostate, with life-altering side effects 🤷‍♂️ Or risk living with the disease In London, surgeon Hashim Ahmed is betting on a 3rd way: focal therapy. My story with @ashleighfurlong.bsky.social tinyurl.com/2rya36ds

For decades, men with prostate cancer faced a binary choice: live with the cancer, or live with the consequences of removing it. This doctor is pushing an alternative that he says is more precise, humane and effective. Gift link to our Businessweek story: t.co/GXLf21gfox

Scoop: J&J is withdrawing a device called Linx that treats acid reflux disease (GERD) from markets outside the US. Surgeons have described the news as devastating and said it will also impacting lung transplant patients. Gift link to story: www.bloomberg.com/news/article...

UK patients on Mounjaro are desperately trying to figure out what they will do when the price rises in Sept. It's led to a surge in interest for Novo Nordisk's Wegovy. It's not an easy decision and there's a bigger looming fear: What if Novo does the same as Lilly? www.bloomberg.com/news/article...

Powerful reporting from @groundup.org.za revealing how Trump's aid cuts have resulted in children dying in Mozambique. groundup.org.za/article/moza...

🚨 NEW TOOL ALERT: Meet NudgeDetect 🚨 Ever felt nudged into clicking "Buy Now", unknowingly subscribing, or paying hidden fees? NudgeDetect is a Chrome extension I’ve built to reveal ‘manipulative’ website tricks: and help you fight back. chromewebstore.google.com/detail/aodlb... 1/5

The pharma industry is flocking to Spain. We wanted to know why. The answer was fascinating: Tax breaks; cheap, good quality science and a government bending over backwards to attract investment. Read the story here (gift link): www.bloomberg.com/news/article...

SCOOP: GSK is pushing the UK government to give pharma companies more access to its public health data troves, to halt the nation’s slide down global life science rankings. Revealed by FOI requests, we found out the gov is assessing the feasibility of the proposal. www.bloomberg.com/news/article...

Gavi's CEO Sania Nishtar isn't accepting the Trump administration's plan to terminate its funding without a fight. Bloomberg interviewed Nishtar as she heads to Washington, hoping to persuade US to reverse a decision that threatens millions of lives. Gift link: www.bloomberg.com/news/article...

Scoop: "The World Health Organization is asking some employees to consider early retirement as the United Nations agency seeks to cut costs following US President Donald Trump’s decision to withdraw."

SCOOP: WHO is asking employees to consider early retirement as it seeks to cut costs following Trump’s decision to withdraw. Staff aged 55 years old or older can retire with 4 months pay, according to copy of confidential email seen by Bloomberg. Gift link: www.bloomberg.com/news/article...

Trump's dramatic remaking of global health means more people will die from preventable conditions, according to scientists and other experts interviewed by Bloomberg. “This is the worst scenario I can possibly imagine,” says virologist Angela Rasmussen. www.bloomberg.com/news/article...

AI drug developer Recursion Pharmaceuticals Inc. is considering an Amazon Prime-style subscription model for selling its pipeline of medicines. We spoke with CEO Chris Gibson this week at the company's King's Cross office about the idea. Gift link: www.bloomberg.com/news/article...

Reliance on private hospitals by the NHS is helping patients get seen quicker than they otherwise would. But it's also fueling a two-track system, benefitting those with less complex conditions. Our big data story w/ @andretartar, @RachelLavin is out: www.bloomberg.com/graphics/202...

Exclusive: Financing for global health has never looked more dire as the world reels from Trump’s dramatic pullback. Now the biggest funder of programs against HIV, tuberculosis and malaria is looking to the UK and others to urgently raise $18 billion. Gift link: www.bloomberg.com/news/article...

Very useful tracker of legal challenges to Trump's admin orders. @ashleighfurlong.bsky.social @publiccitizen.bsky.social

The WHO is having to step in to fill gaps left by the US in the latest Ebola outbreak in Uganda, WHO emergencies chief Mike Ryan told Bloomberg. It comes as WHO head Tedros hit back at Trump's reasons for the US exit from WHO . Story with @janicekew: www.bloomberg.com/news/article...

Guessing that consultants such as myself had better start looking elsewhere. Hate the thought that #WHO may have to start making difficult decisions re their priorities

SCOOP: The World Health Organization is freezing hiring, suspending investments and cutting non-essential travel in response to US President Donald Trump’s decision to take the US out of the global body. News on Bloomberg Terminal. Link to story to come.

🤦🏽‍♀️It's happening. ✂The US has withdrawn from the WHO. 🕳️The first impact of the withdrawal will be on the staff seconded to the WHO from US agencies. 💯Excellent analysis about the impact of this decision by @ashleighfurlong.bsky.social at @bloombergnews.bsky.social 👇🏼 bit.ly/4hkJYvG

The WHO's relationship with China is a key reason for the US exit. That influence could now increase as countries in Asia and the Middle East step into the gap left by the US, Anders Nordström, former acting director-general at the WHO told Bloomberg. Gift link: www.bloomberg.com/news/article...

New paper 📢 The Infected Blood Inquiry (IBI), led by Sir Brian Langstaff, examined one of the UK's largest public health scandals: 30,000 infections & 3,000+ deaths from infected blood products (1970–90s). Thread below.

I’m a health reporter and I’m looking to speak to patients who have received NHS-funded operations at private hospitals in England. I would love to chat about your experience. DM me or email me at [email protected] #journorequest #privatehealthcare #NHS

UK cancer patients are being denied access to drugs as the regulator, drugmakers & government stand-off over prices. A complex and difficult story to write, but one that I think encapsulates the challenges of access to new drugs in the UK. Gift link: www.bloomberg.com/news/article...